Form 4 for HCAT Health Catalyst, Inc.
Accepted 2026-02-27 00:00:00 ET · period of report 2026-02-25 · accession 0002086403-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-27 | 2026-02-26 | HCAT | Albert Benjamin | CEO, Dir | F - Tax | $1.75 | -13.3K | 1.53M | -0.9% | -$23.3K | |
| M | 2026-02-27 | 2026-02-25 | HCAT | Albert Benjamin | CEO, Dir | A - Grant | $0.00 | +968.8K | 1.55M | +168% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-26 | F | D | 13,304 | $1.75 | 1,533,399 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-25 | A | A | 930,000 | $0.00 | 1,507,870 | D | — | — | (F1) Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 16.67% of the RSUs will vest on March 1st, 2026, and, thereafter, the remaining 83.33% of the RSUs will vest in 10 equal quarterly installments. |
| 3 | Common | Common Stock | 2026-02-25 | A | A | 38,833 | $0.00 | 1,546,703 | D | — | — | (F2) Represents an award of 38,833 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2025. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. |